skip to Main Content

Medicare (CMS) January 6th 2019 Local Coverage Determination (LCD) Updates

Medicare (CMS) January 6th 2019 Local Coverage Determination (LCD) Updates
Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

January 6th 2019 Medicare (CMS) LCD Updates:

  • A56243              2019 HCPCS Part A/B, Part A and Part B local coverage determination changes
  • L36466 (retired) Application of Skin Substitutes
  • A56141              Billing and Coding for Chemotherapy
  • A55944 (retired) Billing and Coding for the Rezum® System for Benign Prostatic Hyperplasia (BPH)
  • A55035 (retired) Billing Requirements for Application of Skin Substitutes (Part B Services Only)
  • L34411              Blepharoplasty, Eyelid Surgery, and Brow Lift
  • A56246              Bortezomib (Velcade) revision to the Part A and Part B LCD
  • L33273              Bortezomib (Velcade®)
  • L33422              Brain Natriuretic Peptide (BNP) Level
  • L36499              BRCA1 and BRCA2 Genetic Testing
  • A55723              Coding for Hemodialysis Sessions
  • A56262              Coding for Hemodialysis Sessions
  • L36393              Controlled Substance Monitoring and Drugs of Abuse Testing
  • L35698              CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing
  • A55967 (retired) Durolane® Coding and Billing Guidelines
  • L37398              Electroretinography (ERG)
  • L36230              Evaluation and Management Services in a Nursing Facility
  • L34974 (retired) Facet Joint Injections
  • L35014              Frequency of Hemodialysis
  • L37564              Frequency of Hemodialysis
  • A56264              Frequency of hemodialysis – new Part A and Part B LCD
  • L33684              Hemophilia Clotting Factors
  • A56261              Independent diagnostic testing facility (IDTF) revision to the Part B LCD “Coding Guideline” attachment
  • L33704              Infliximab (Remicade TM )
  • L37022              Lab: Coenzyme Q10 (CoQ10)
  • A55695              MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML) Coding and Billing Guidelines
  • L37033              MolDX: DecisionDx-UM (Uveal Melanoma)
  • L37264              MolDX: EndoPredict Breast Cancer Gene Expression Test
  • L36174 (retired) MolDX: NSCLC, Comprehensive Genomic Profile Testing
  • L37744              MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
  • L37746              MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
  • L34519              Molecular Pathology Procedures
  • L33777              Noncovered Services
  • L33747              Pegfilgrastim (Neulasta®)
  • L33624              Psychiatric Inpatient Hospitalization
  • L33972              Psychiatric Partial Hospitalization Program
  • A56037              Psychiatric Partial Hospitalization Program Coding Guidelines
  • L34520              Psychological and Neuropsychological Tests
  • A56224              Response to Comments: Frequency of Hemodialysis
  • A56263              Response to Comments: Frequency of Hemodialysis L37564
  • A56256              Response to Comments: MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
  • A56257              Response to Comments: MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
  • L33746              Rituximab (Rituxan®)
  • A56244              Self-administered drug (SAD) list revision to the Part A and Part B article
  • A52571              Self-Administered Drug Exclusion List
  • L36035              Spinal Cord Stimulation for Chronic Pain
  • L34223              Stereotactic Radiosurgery
  • L33413              Therapy and Rehabilitation Services
  • A56245              Therapy and rehabilitation services – revision to the Part A and Part B LCD
  • L33767              Viscosupplementation Therapy For Knee

 

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

 

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Back To Top